Vnitr Lek 2013, 59(10):909-931

Doporučení pro diagnostiku a léčbu onemocnění štítné žlázy v těhotenství a pro ženy s poruchou fertility

J. Horáček1, J. Jiskra2, Z. Límanová2,*, D. Springer3, V. Zamrazil4
1 IV. interní hematologická klinika Lékařské fakulty UK a FN Hradec Králové, přednosta doc. MUDr. Pavel Žák, Ph.D.
2 III. interní klinika 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA
3 Ústav lékařské biochemie a laboratorní diagnostiky 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Tomáš Zima, DrSc., MBA
4 Endokrinologický ústav Praha, ředitelka doc. RNDr. Běla Bendlová, CSc.

Published: October 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horáček J, Jiskra J, Límanová Z, Springer D, Zamrazil V. Doporučení pro diagnostiku a léčbu onemocnění štítné žlázy v těhotenství a pro ženy s poruchou fertility. Vnitr Lek. 2013;59(10):909-931.
Download citation

References

  1. Abalovich M, Amino N, Barbour LA et al. Clinical Practice Guideline. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007; 92 (Suppl 8): S1-S47. Go to original source... Go to PubMed...
  2. Achiron A, Kishner I, Dolev M et al. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 2004; 251: 1133-1137. Go to original source... Go to PubMed...
  3. Alexander EK, Marqusee E, Lawrence J et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004; 351: 349-353. Go to original source... Go to PubMed...
  4. Auso E, Lavado-Autric R, Cuevas E et al. A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 2004; 145: 4037-4044. Go to original source... Go to PubMed...
  5. Barbero P, Valdez R, Rodriguez H et al. Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet 2008; 146: 2390-2395. Go to original source... Go to PubMed...
  6. Bath SC, Rayman MP. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 2012; 366: 1640-1641. Go to original source... Go to PubMed...
  7. Benhadi N, Wiersinga WM, Reitsma JB et al. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal and neonatal death. Eur J Endocrinol 2009; 160: 985-991. Go to original source... Go to PubMed...
  8. Braverman LE, Utiger RD. Introduction to thyrotoxicosis. In: Braverman LE, Utiger RD (eds). Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. 9th ed. Philadelphia: Lippincott, Williams and Wilkins 2005: 453-455.
  9. Brent GA. The debate over thyroid function screening in pregnancy. N Engl J Med 2012; 366: 562-563. Go to original source... Go to PubMed...
  10. Carmichael SL, Shaw GM, Ma C et al. National Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007; 197: 585: discussion 683-684. Go to original source... Go to PubMed...
  11. Casey BM, Dashe JS, Wells CE et al. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006; 107: 337-341. Go to original source... Go to PubMed...
  12. Cassina M, Dona M, Di'Gianantonio E et al. Pharmacologic treatment of hyperthyroidism during pregnancy. Birth Defects Res A Clin Mol Teratol 2012; 94: 612-619. Go to original source... Go to PubMed...
  13. Clementi M, Di'Gianantonio E, Cassina M et al. SAFE-Med Study Group. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab 2010; 95: E337-E341. Go to original source... Go to PubMed...
  14. Clementi M, Di'Gianantonio E, Pelo E et al. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 1999; 83: 43-46. Go to original source... Go to PubMed...
  15. Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009; 19: 1167-1214. Go to original source... Go to PubMed...
  16. Costante G, Meringolo D, Durante C et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 2007; 92: 450-455. Go to original source... Go to PubMed...
  17. De Groot L, Abalovich M, Alexander EK et al. Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society practice guidelines. J Clin Endocrinol Metab 2012; 97: 2543-2565. Go to original source... Go to PubMed...
  18. Delange F. Optimal iodine nutrition during pregnancy, lactation and the neonatal period. J Clin Endocrinol Metab 2004; 2: 1-12.
  19. Dosiou C, Sanders GD, Araki SS et al. Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. Eur J Endocrinol 2008; 158: 841-851. Go to original source... Go to PubMed...
  20. Dosiou C, Barnes J, Schwartz A et al. Cost-effectiveness of universal and risk-based screening for autoimmune thyroid disease in pregnant women. J Clin Endocrinol Metab 2012; 97: 1536-1546. Go to original source... Go to PubMed...
  21. Galofre JC, Haber RS, Mitchell AA et al. Increased postpartum thyroxine replacement in Hashimoto's thyroiditis. Thyroid 2010; 20: 901-908. Go to original source... Go to PubMed...
  22. Garsi JP, Schlumberger M, Rubino C et al. Therapeutic administration of 1311 for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies. J Nucl Med 2008; 49: 845-852. Go to original source... Go to PubMed...
  23. Ghassabian A, Bongers-Schokking JJ, de Rijke YB. Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the Generation R Study. Thyroid 2012; 22: 178-186. Go to original source... Go to PubMed...
  24. Gibelli B, Zamperini P, Tradati N. Pregnancy and thyroid cancer. Recent Results Cancer Res 2008; 178: 123-126. Go to original source... Go to PubMed...
  25. Glinoer D, Soto MF, Bourdoux P et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 1991; 73: 421-427. Go to original source... Go to PubMed...
  26. Glinoer D, Riahi M, Grun JP et al. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 1994; 79: 197-204. Go to original source...
  27. Haas J. High dose IVIG in the post partum period for prevention of exacerbations in MS. Mult Scler 2000; 6 (Suppl 2): 18-20: discussion 33. Go to original source...
  28. Hartl DM, Travagli JP. The Updated American Thyroid Association Guidelines for Management of Thyroid Nodules and Differentiated thyroid cancer. A surgical perspective. Thyroid 2009; 19: 1149-1151. Go to original source... Go to PubMed...
  29. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003; 24: 102-132. Go to original source... Go to PubMed...
  30. Hirsch D, Levy S, Tsvetov G et al. Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. Thyroid 2010; 20: 1179-1185. Go to original source... Go to PubMed...
  31. Horacek J, Spitalnikova S, Dlabalova B et al. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. Eur J Endocrinol 2010; 163: 645-650. Go to original source... Go to PubMed...
  32. Chang DL, Leung AM, Braverman LE et al. Thyroid testing during pregnancy at an academic Boston Area Medical Center. J Clin Endocrinol Metab 2011; 96: E1452-E1433. Go to original source... Go to PubMed...
  33. Jiskra J, Bartáková J, Holinka S et al. Low concordance between positive antibodies to thyroperoxidase and thyroid ultrasound autoimmune pattern in pregnant women. Endocr J 2011; 58: 849-859. Go to original source... Go to PubMed...
  34. Jiskra J, Bartáková J, Holinka Š et al. Low prevalence of clinically high-risk women and pathological thyroid ultrasound among pregnant women positive in universal screening for thyroid disorders. Exp Clin Endocrinol Diabetes 2011; 119: 530-535. Go to original source... Go to PubMed...
  35. Krassas GE, Poppe K, Glinoer G. Thyroid function and human reproductive health. Endocr Rev 2010; 31: 702-755. Go to original source... Go to PubMed...
  36. Kung AW, Chau MT, Lao TT et al. The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab 2002; 87: 1010-1014. Go to original source... Go to PubMed...
  37. Lazarus JH. Thyroid screening in pregnancy. In: Lazarus JH, Pirags V, Butz S (eds). The thyroid and reproduction. Merck European Thyroid Symposium. Stuttgart: Georg Tieme Verlag 2008: 105-113. Go to original source...
  38. Lazarus JH, Betswick JP, Channon S et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 2012; 366: 493-501. Go to original source... Go to PubMed...
  39. Lee M, O'Brien P. Pregnancy and multiple sclerosis. J Neurol Neurosurg Psychiatry 2008; 79: 1308-1311. Go to original source... Go to PubMed...
  40. Límanová Z, Zamrazil V. Má být zaveden screening funkčních tyreoidálních onemocnění u dospělých v České republice? DMEV 2004; 7: 124-130.
  41. Límanová Z, Springer D. Současné zkušenosti s vyšetřováním tyreopatií v graviditě - výsledky pilotního projektu. Čas Lék Česk 2011; 150: 389-393. Go to PubMed...
  42. Marley F, Oertel YC. Fine needle aspiration of thyroid lesions in 57 pregnant and postpartum women. Diagn Cytopathol 1997; 16: 122-125. Go to original source... Go to PubMed...
  43. McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptorantibodies. Thyroid 1992; 2: 155-159. Go to original source... Go to PubMed...
  44. Morreale de Escobar G, Obregon MJ, del Rey FE. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 2004; 18: 225-248. Go to original source... Go to PubMed...
  45. Negro R, Mangieri T, Coppola L et al. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod 2005; 20: 1529-3346. Go to original source... Go to PubMed...
  46. Negro R, Formoso G, Mangieri T et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006; 91: 2587-2591. Go to original source... Go to PubMed...
  47. Negro R, Schwartz A, Gismondi R et al. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010; 95: 1699-1707. Go to original source... Go to PubMed...
  48. Negro R, Soldin OP, Obregon MJ et al. Hypothyroxinemia and pregnancy. Endocr Pract 2011; 17: 422-429. Go to original source... Go to PubMed...
  49. Negro R, Schwartz A, Gismondi R et al. Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J Clin Endocrinol Metab 2011; 96: E920-E924. Go to original source... Go to PubMed...
  50. Negro R, Stagnaro-Green A. Thyroid antibodies, preterm birth, and miscarriage. The association is clear, but the effects of levothyroxine treatment are uncertain. Brit Med J 2011; 342: d2260. Go to original source... Go to PubMed...
  51. Niebyl JR. Clinical practice. Nausea and pregnancy. N Engl J Med 2010; 363: 1544-1550. Go to original source... Go to PubMed...
  52. Nüssgens Z, Roggenkämper P, Schweikert HU. Development of endocrine orbitopathy in pregnancy. Klin Monbl Augenheilkd 1993; 202: 130-133. Go to original source... Go to PubMed...
  53. Osorio J. Thyroid screening in pregnancy - no effect on child cognition? Nat Rev Endocrinol 2012; 8: 193. Go to original source... Go to PubMed...
  54. Pacini F, Schlumberger M, Dralle H et al. European Thyroid Cancer Taskforce - European Thyroid Cancer Taskforce 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787-803. Go to original source... Go to PubMed...
  55. Pacini F, Schlumberger M, Dralle H et al. European Thyroid Cancer Taskforce A systematic review examining the effect of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxf) 2008; 69: 479-490. Go to original source... Go to PubMed...
  56. Patil-Sisodia K, Mestman JH. Graves hyperthyroidism 2010 Graves hyperthyroidism and pregnancy: a clinical update. Endocr Pract 2010; 16: 118-129. Go to original source... Go to PubMed...
  57. Pop V, Brouwers EP, Vader HL et al. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol 2003; 59: 282-288. Go to original source... Go to PubMed...
  58. Potlukova E, Potluka O, Jiskra J et al. Is Age a Risk Factor for Hypothyroidism in Pregnancy? An Analysis of 5223 Pregnant Women. J Clin Endocrinol Metab 2012; 97: 1945-1952. Go to original source... Go to PubMed...
  59. Rosen IB, Walfish PG. Pregnancy as a predisposing factor in thyroid neoplasia. Arch Surg 1986; 121: 1287-1290. Go to original source... Go to PubMed...
  60. Rubin PC. Current concepts: beta-blockers in pregnancy. N Engl J Med 1981; 305: 1323-1326. Go to original source... Go to PubMed...
  61. Russo MW, Galanko JA, Shrestha R et al. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006; 107: 337-341. Go to original source... Go to PubMed...
  62. Smith LH, Danielsen B, Allen ME et al. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 2003; 189: 1128-1135. Go to original source... Go to PubMed...
  63. Springer D, Horáček J, Hauerová D et al. Poruchy štítné žlázy v těhotenství - souhrn výsledků nezávislých studií. Čes Gynek 2007; 72: 375-381.
  64. Springer D, Zima T, Limanova Z. Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol 2009; 160: 791-797. Go to original source... Go to PubMed...
  65. Stafford IP, Dildy GA 3rd, Miller JM Jr. Severe Graves' ophthalmopathy in pregnancy. Obstet Gynecol 2005; 105: 1221-1223. Go to original source... Go to PubMed...
  66. Stagnaro-Green A, Abalovich M, Alexander E et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21: 1-45. Go to original source... Go to PubMed...
  67. Stagnaro-Green A, Schwartz A, Gismondi R et al. High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroidits in southern Italy. J Clin Endocrinol Metab 2011; 96: 652-657. Go to original source... Go to PubMed...
  68. Struve CV, Haupt S, Ohlen S. Influence in frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease. Thyroid 1993; 3: 7-9. Go to original source... Go to PubMed...
  69. Tan GH, Gharib H, Goellner JR et al. Management of thyroid nodules in pregnancy. Arch Intern Med 1996; 156: 122-125. Go to original source...
  70. Tan JY, Loh KC, Yeo GS et al.Transient hyperthyroidism of hyperemesis gravidarum. BJOG 2002; 109: 683-688. Go to original source... Go to PubMed...
  71. Telička Z, Jiskra J, Springer D. Simple Method of Economical Analysis of Diagnosis Procedure (Used in Screening of Thyroid Gland Diseases in Pregnant Women) during the first trimester of pregnancy. E J Biomed Inf. Prague 2010 [online]. Available from: http://ejbi.cz/articles/201012/59/1.html.
  72. Thangaratinam S, Tan A, Knox E et al. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. Brit Med J 2011; 342: d2616. Go to original source... Go to PubMed...
  73. Thung SF, Funai EF, Grobman WA. The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism. Am J Obstet Gynecol 2009: 267: e1-e7. Go to original source... Go to PubMed...
  74. Vaidya B, Anthony S, Bilous M et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high risk case finding? J Clin Endocrinol Metab 2007; 92: 203-207. Go to original source... Go to PubMed...
  75. Wang W, Teng W, Shan Z et al. The prevalence of thyroid disorders during early pregnancy in China: the benefits of universal screening in the first trimester of pregnancy. Eur J Endocrinol 2011; 164: 263-268. Go to original source... Go to PubMed...
  76. Wiliams GR. Neurodevelopment and neurophysiological actions of thyroid hormone. J Neuroendocrinol 2008; 20: 784-794. Go to original source... Go to PubMed...
  77. Yassa L, Marqusee E, Fawcett R et al. Thyroid hormone early adjustment in pregnancy (the THERAPY trial). J Clin Endocrinol Metab 2010; 95: 3234-3241. Go to original source... Go to PubMed...
  78. Yoshira A, Noh J, Yamaguchi T et al. Treatment of Grave's disease with antithyroid drugs in the first trimestr of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 2012; 97: 2396-403. Go to original source... Go to PubMed...
  79. Zamrazil V, Bilek R, Cerovska J et al. The elimination of iodine deficiency in the Czech Republic: the steps toward success. Thyroid 2004; 14: 49-56. Go to original source... Go to PubMed...
  80. Zamrazil V, Bílek R, Čeřovská J et al. Jodový deficit ve světě i v České republice - současný stav a perspektivy. Vnitř Lék 2010; 56: 1310-1315. Go to PubMed...
  81. Zimmermann M, Delange F. Iodine supplementation of pregnant women in Europe. A review and recomendation. Eur J Clin Nutr 2004; 58: 979-984. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.